Skip to Main Content

Paper Details

Metabolic network failures in Alzheimer's disease: A biochemical road map.
Alzheimers Dement
288
2017
-aminoadipic acid, A1-42, AD, Alzheimer's Disease, Alzheimer's disease, acylcarnitines, amines, branched-chain amino acid, ether, mild cognitive impairment, participants, patients, phosphatidylcholines, sphingomyelins, tau, valine
Author NameAffiliation
Rui ChangIcahn School of Medicine at Mount Sinai
Jessica D TenenbaumDuke University
Alison A Motsinger-ReifBioinformatics Research Center, North Carolina State University
Shannon L RisacherIndiana University School of Medicine
Sungeun KimIndiana University School of Medicine
Kwangsik NhoIndiana University School of Medicine
Kwangsik NhoIndiana University School of Medicine
Li ShenIndiana University School of Medicine
Sudhir VarmaClinical and Translational Neuroscience Unit, National Institute on Aging, National Institutes of Health
Sudhir VarmaClinical and Translational Neuroscience Unit, National Institute on Aging, National Institutes of Health
Martin A MoseleyCenter for Genomic and Computational Biology, Duke University
Ayse Demirkan
Cornelia M van DuijnLeiden Academic Centre for Drug Research, Leiden University
Cornelia M van DuijnLeiden Academic Centre for Drug Research, Leiden University
John Q TrojanowskiUniversity of Pennsylvania
Leslie M ShawUniversity of Pennsylvania
Andrew J SaykinIndiana University School of Medicine
Andrew J SaykinIndiana University School of Medicine
Michael W WeinerCenter for Imaging of Neurodegenerative Diseases, San Francisco VA Medical Center/University of California San Francisco
Pudugramam Murali DoraiswamyDuke University, USA Duke Institute for Brain Sciences
  • 1 - 20

Datasets